2020年度

Hirayama M, Wei FY, Chujo T, Oki S, Yakita M, Kobayashi D, Araki N, Takahashi N, Yoshida R, Nakayama H, Tomizawa K.
FTO Demethylates Cyclin D1 mRNA and Controls Cell-Cycle Progression.
Cell Rep. 31(1):107464, 2020.

Toya R, Saito T, Matsuyama T, Kai Y, Shiraishi S, Murakami D, Yoshida R, Watakabe T, Sakamoto F, Tsuda N, Arimura H, Orita Y, Nakayama H, Oya N
Diagnostic Value of FDG-PET/CT for the Identification of Extranodal Extension in Patients with Head and Neck Squamous Cell Carcinoma.
Anticancer Res. 40(4):2073-7, 2020.

Yoshida R, Nagata M, Hirosue A, Kawahara K, Nakamoto M, Hirayama M, Takahashi N, Matsuoka Y, Sakata J, Nakashima H, Arita H, Hiraki A, Shinohara M, Kikuchi K, Nakayama H.
Yoshida R, Nagata M, Hirosue A, Kawahara K, Nakamoto M, Hirayama M, Takahashi N, Matsuoka Y, Sakata J, Nakashima H, Arita H, Hiraki A, Shinohara M, Kikuchi K, Nakayama H.
PLoS One. 15(4):e0231656, 2020.

Burke, M. J., R. Kostadinov, R. Sposto, L. Gore, S. M. Kelley, C. Rabik, J. B. Trepel, M. J. Lee, A. Yuno, S. Lee, D. Bhojwani, S. Jeha, B. H. Chang, M. L. Sulis, M. L. Hermiston, P. Gaynon, V. Huynh, A. Verma, R. Gardner, K. M. Heym, R. M. Dennis, D. S. Ziegler, T. W. Laetsch, J. E. Oesterheld, S. G. Dubois, J. A. Pollard, J. Glade-Bender, T. M. Cooper, J. A. Kaplan, M. S. Farooqi, B. Yoo, E. Guest, A. S. Wayne and P. A. Brown.
Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study.
Clin Cancer Res 26(10): 2297-2307, 2020

Toya R, Saito T, Yamaguchi K, Matsuyama T, Watakabe T, Matsumoto T, Yoshida R, Hirosue A, Murakami D, Orita Y, Nakayama H, Oya N.
Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 "QUAD shot" regimen for incurable head and neck cancer.
Radiat Oncol. 15(1):123, 2020.

Naito H, Sueta D, Nakayama H, Araki E, Tanihara H, Kasaoka S, Tsujita K.
Clinical features of disaster-associated direct deaths during recent inland earthquakes in Japan.
Tohoku J Exp Med. 251(3):169-73, 2020.

Lampert, E. J., A. Cimino-Mathews, J. S. Lee, J. Nair, M. J. Lee, A. Yuno, D. An, J. B. Trepel, E. Ruppin and J. M. Lee.
Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses.
J Immunother Cancer 8(2), 2020

Yamamoto T, Hirosue A, Nakamoto M, Yoshida R, Sakata J, Matsuoka Y, Kawahara K, Nagao Y, Nagata M, Takahashi N, Hiraki A, Shinohara M, Nakao M, Saitoh N, Nakayama H.
BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene.
Br J Cancer. 123(4):580-590, 2020.

Apolo, A. B., R. Nadal, Y. Tomita, N. N. Davarpanah, L. M. Cordes, S. M. Steinberg, L. Cao, H. L. Parnes, R. Costello, M. J. Merino, L. R. Folio, L. Lindenberg, M. Raffeld, J. Lin, M. J. Lee, S. Lee, S. V. Alarcon, A. Yuno, N. A. Dawson, K. Allette, A. Roy, D. De Silva, M. M. Lee, T. M. Sissung, W. D. Figg, P. K. Agarwal, J. J. Wright, Y. M. Ning, J. L. Gulley, W. L. Dahut, D. P. Bottaro and J. B. Trepel.
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial.
Lancet Oncol 21(8): 1099-1109, 2020

Gatti-Mays, M. E., F. H. Karzai, S. N. Soltani, A. Zimmer, J. E. Green, M. J. Lee, J. B. Trepel, A. Yuno, S. Lipkowitz, J. Nair, A. McCoy and J. M. Lee.
A Phase II Single Arm Pilot Study of the CHK1 Inhibitor Prexasertib (LY2606368) in BRCA Wild-Type, Advanced Triple-Negative Breast Cancer.
Oncologist 25(12): 1013-e1824, 2020

Kawahara K, Hiraki A, Arita H, Takeshita H, Hirosue A, Matsuoka Y, Sakata J, Obayashi Y, Nakashima H, Hirayama M, Nagata M, Yoshida R, Shinohara M, Nakayama H.
Role of serum amylase and salivary cytokines in oral complications during chemoradiotherapy.
Oral Dis. doi: 10.1111/odi.13686. Epub ahead of print, 2020.

Kageyama S, Nagao Y, Ma J, Asakawa M, Yoshida R, Takeshita T, Hirosue A, Yamashita Y, Nakayama H. Compositional Shift of Oral Microbiota Following Surgical Resection of Tongue Cancer.
Front Cell Infect Microbiol. 10:600884, 2020.

Yoshida R, Gohara S, Sakata J, Matsuoka Y, Hirosue A, Kawahara K, Kawaguchi S, Nagao Y, Yamana K, Nagata M, Fukuma D, Toya R, Murakami R, Hiraki A, Shinohara M, Nakayama H.
Onodera's prognostic nutritional index correlates with tumor immune environment and survival in patients with oral squamous cell carcinoma undergoing chemoradiotherapy.
Transl Oncol. 13(12):100850, 2020.

Takahashi N, Hiraki A, Kawahara K, Nagata M, Yoshida R, Matsuoka Y, Tanaka T, Obayashi Y, Sakata J, Nakashima H, Arita H, Shinohara M, Nakayama H.
Postoperative delirium in patients undergoing tumor resection with reconstructive surgery for oral cancer.
Mol Clin Oncol. 14(3):60, 2021.

Lee, M. J., Y. Tomita, A. Yuno, S. Lee, N. E. Abrouk, B. Oronsky, S. Caroen and J. B. Trepel.
Results from a biomarker study to accompany a phase II trial of RRx-001 with reintroduced platinum-based chemotherapy in relapsed small cell carcinoma.
Expert Opin Investig Drugs 30(2): 177-183, 2021.

Hellmann, M. D., P. A. Janne, M. Opyrchal, N. Hafez, L. E. Raez, D. I. Gabrilovich, F. Wang, J. B. Trepel, M. J. Lee, A. Yuno, S. Lee, S. Brouwer, S. Sankoh, L. Wang, D. Tamang, E. V. Schmidt, M. L. Meyers, S. S. Ramalingam, E. Shum and P. Ordentlich.
Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 Therapy.
Clin Cancer Res 27(4): 1019-1028, 2021

Minamitake A, Murakami R, Sakamoto F, Yoshida R, Sakata J, Hirosue A, Kawahara K, Yamana K, Nakayama H, Toya R, Shiraishi S.
Can MRI-derived depth of invasion predict nodal recurrence in oral tongue cancer?
Oral Radiol. doi: 10.1007/s11282-020-00505-3. Epub ahead of print, 2021.

Maeshiro M, Shinriki S, Liu R, Nakachi Y, Komohara Y, Fujiwara Y, Ohtsubo K, Yoshida R, Iwamoto K, Nakayama H, Matsui H.
Colonization of distant organs by tumor cells generating circulating homotypic clusters adaptive to fluid shear stress.
Sci Rep. 11(1):6150, 2021.